Understanding muscle weakness caused by TPM3 gene mutations and finding new treatments
Unveiling the molecular mechanisms in TPM3-related myopathy and therapies
This study is looking into the genetic reasons behind TPM3-related myopathy, which causes muscle weakness, and aims to find new treatments by creating animal models that mimic the condition.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Children's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10670411 on NIH RePORTER |
What this research studies
This research investigates the genetic causes of TPM3-related myopathy, a condition that leads to muscle weakness and affects quality of life. The team is using advanced techniques like CRISPR to create animal models, including mice and zebrafish, that mimic the disease in humans. By studying these models, they aim to uncover the underlying muscle pathology and identify potential therapeutic strategies. The research also includes developing drug screening assays to test new treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with TPM3-related myopathy, particularly those with specific mutations in the TPM3 gene.
Not a fit: Patients with muscle disorders not related to the TPM3 gene may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective therapies for patients suffering from TPM3-related myopathy.
How similar studies have performed: Other research has successfully utilized animal models to uncover treatments for genetic muscle disorders, indicating a promising approach in this area.
Where this research is happening
Boston, United States
- Boston Children's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Lambert, Matthias — Boston Children's Hospital
- Study coordinator: Lambert, Matthias
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.